Navigation Links
Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper
Date:4/14/2011

s and uncertainties, many of which are difficult to predict and include statements regarding the use of zinc as a potential treatment for cognitive deficits in Alzheimer's patients and our intent to further commercialize development of reaZin as a prescription  medical food. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, our failure to successfully commercialize reaZin for the treatment of Alzheimer's disease, the failure of reaZin to be accepted as a treatment for Alzheimer's disease,  failure of future clinical trials studying  reaZin to have favorable results, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

(1) O'Brien, P.C., "Procedures for Comparing Samples with Multiple Endpoints," Biometrics, 40, 1079-1087, 1984.

(2) Squitti, R., Pasqualetti, P., Dal Forno, G., et al., "Excess of serum copper not related to ceruloplasmin in Alzheimer disease," Neurology, vol. 64, no. 6, pp 1040-1046, 2005.

(3) Squitti, R., Barbati, G., Rossi, L., et al., "Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau," Neurology, vol. 67, no. 1, pp 76-82, 2006.

(4) Squitti, R., Bressi, P., Pasqualetti, R, et al., "Longitudinal prognostic value of serum "free" copper in patients with Alzheimer's disease," Neurol
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
2. New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions
3. GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
4. Visual Healthcare to Support Chinese Clinical Trials
5. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
6. Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
7. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
8. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
9. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
10. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
11. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... LAS VEGAS , Jan. 23, 2015 Cord Blood ... CBAI ) ("CBAI" or the "Company")  filed a Preliminary Proxy ... ( www.sec.gov ) today, and provides an update for shareholders ... authorized shares is requested. Dear Shareholders, ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... , GENEVA, Switzerland, December 14 ... Meeting was held,in Bermuda on 7th December. In excess of ... and overwhelmingly approved all the resolutions,put forward. , ... Shortt of Galmoy,as the new Director of Corporate Communications. In ...
... , , STUART, ... LBMH) is pleased to announce the addition of Mr. Joseph Farish ... Farish is s graduate of the University of Florida (Bachelor of ... has been a member of the Florida Bar for more than ...
Cached Medicine Technology:Calcitech Holds Annual General Meeting 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... The University HealthSystem Consortium (UHC) introduced the Tactics ... center to help its academic medical center members ... challenges of the current economic conditions have increased ... cost reduction initiatives and ideas. UHC,s Tactics ...
... had deficient levels, study shows , , WEDNESDAY, April 29 (HealthDay ... ill patients, new research shows. , In a small study, ... intensive care unit were deficient in vitamin D. , "Vitamin ... patients," said study author Dr. Paul Lee, an endocrinologist and ...
... ongoing debate regarding Hormone Replacement Therapy has been raging ... results of a controversial study released in 2002 have ... how to deal with unpleasant menopausal hormone symptoms caused ... and figures such as Oprah Winfrey, Suzanne Somers and ...
... GuidanceST. LOUIS, April 29 Express Scripts, Inc. (Nasdaq: ... operations of $214.7 million, or $0.86 per diluted share, which ... 2008. The Company reported first quarter cash flow from continuing ... year. "It has been a strong start to 2009 ...
... April 29 A drug widely used to treat ... legs syndrome (RLS) and helps people with the disorder get a ... as part of the Late-breaking Science Program at the American Academy ... 2, 2009. RLS affects up to one in ten people.The ...
... dangerous levels of artery-blocking proteins , , WEDNESDAY, April 29 ... artery disease has worked well in a small trial, ... of the protein collagen, which plays a major role ... von zur Muehlen, a fellow in cardiology at University ...
Cached Medicine News:Health News:University HealthSystem Consortium Launches Tactics for Tough Times Initiative to Help Members With Issues Such as Capacity and Medication Management 2Health News:Critically Ill Patients Lack Vitamin D 2Health News:Critically Ill Patients Lack Vitamin D 3Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 2Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 2Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 4Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 5Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 6Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 7Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 8Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 9Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 10Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 11Health News:New Treatment Discovered for Restless Legs Syndrome Improves Sleep 2Health News:Urine Test for Heart Disease Shows Promise 2
... Available in even sizes 20-36F. A ... patient comfort., ,The Latex-Free Robertazzi ... patient comfort while offering the best ... economically priced allowing you to offer ...
Silkolatex™ . Adjustable flange. Single use....
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Medicine Products: